A potential diagnostic blood test for attention deficit hyperactivity disorder
Douglas B Woodruff1, Rif S El-Mallakh, Alagu P Thiruvengadam
1Baltimore, MD 21211, USA.
Attention Deficit and Hyperactivity Disorders
|April 28, 2011
Summary
A new blood test measuring membrane potential ratio (MPR™) shows promise for diagnosing attention deficit hyperactivity disorder (ADHD). This objective test could aid in the controversial diagnosis of ADHD across all age groups.
Area of Science:
- Neuroscience
- Biomarkers
- Diagnostic Tools
Background:
- Diagnosis of attention deficit hyperactivity disorder (ADHD) is often controversial due to subjective diagnostic procedures.
- The increasing diagnosis rates in children, adolescents, and adults highlight the need for more objective diagnostic methods.
- A novel blood test measuring blood cell membrane potential, termed membrane potential ratio (MPR™), has been developed.
Purpose of the Study:
- To investigate the potential diagnostic utility of the MPR™ blood test for ADHD.
- To assess the accuracy of MPR™ in differentiating individuals with and without ADHD.
Main Methods:
- A cross-sectional study involving consecutive outpatients (children, adolescents, adults) diagnosed with ADHD or without.
- Blood samples were collected to measure the membrane potential ratio (MPR™).
- Statistical analysis compared MPR™ values between ADHD and non-ADHD groups.
Main Results:
- Individuals with ADHD exhibited significantly higher MPR™ values (0.804 ± 0.0381) compared to non-ADHD individuals (0.684 ± 0.0260; P < 0.05).
- The MPR™ test demonstrated a sensitivity ranging from 0.75 to 0.9 and a specificity of 0.75.
- These findings suggest a depolarization in ADHD subjects compared to controls.
Conclusions:
- The MPR™ blood test shows potential as a viable diagnostic tool for ADHD.
- Further research with larger, standardized studies is warranted to confirm these findings, considering medication and comorbidity.
- Exploration of age and gender variables in relation to MPR™ is recommended.


